In animal embryos, transcription is mostly silent for several cell divisions, until the release of the first major wave of embryonic transcripts through so-called zygotic genome activation (ZGA) 1 . Maternally provided ZGA-triggering factors have been identified in Drosophila melanogaster and Danio rerio 2,3 , but their mammalian homologs are still undefined. Here, we provide evidence that the DUX family of transcription factors 4,5 is essential to this process in mice and potentially in humans. First, human DUX4 and mouse Dux are both expressed before ZGA in their respective species. Second, both orthologous proteins bind the promoters of ZGA-associated genes and activate their transcription. Third, Dux knockout in mouse embryonic stem cells (mESCs) prevents the cells from cycling through a 2-cell-like state. Finally, zygotic depletion of Dux leads to impaired early embryonic development and defective ZGA. We conclude that DUX-family proteins are key inducers of zygotic genome activation in placental mammals.
Dux genes encode double-homeodomain proteins and are conserved throughout placental mammals 4, 5 . Human DUX4, the intronless product of an ancestral DUXC, is nested within the D4Z4 macrosatellite repeat of chromosome 4 as an array of 10 to 100 units (ref. 6) . DUX4, DUXC, and Dux genes from other placental mammals display the same repetitive structure: DUX4 from primates and Afrotheria and DUXC from cows and other Laurasiatheria localize at telomeric or pericentromeric regions, and mouse Dux tandem repeats lie adjacent to a mouse-specific chromosomal fusion point that resembles a subtelomeric structure 4, 5 .
Overexpression-inducing mutations in DUX4 are associated with facioscapulohumeral muscular dystrophy (FSHD), the third most common muscular dystrophy 7, 8 , and forced DUX4 production in human primary myoblasts leads to upregulation of genes active during early embryonic development 9 . On the basis of this premise, we analyzed publicly available RNA-seq data sets corresponding to this period, focusing on DUX4 and the 100 genes most upregulated in DUX4-overexpressing muscle cells 10, 11 (Fig. 1a and Supplementary  Table 1 ). DUX4 RNA was detected from the oocyte to 4-cell (4C) stages, whereas transcripts from putative DUX4 targets emerged on average at the 2-cell (2C) stage and peaked at the 8-cell (8C) stage, as previously defined for human ZGA 12 . Transcripts upregulated in DUX4-overexpressing muscle cells 11 were also enriched at the 8C stage ( Supplementary Fig. 1a,b) , and after clustering of genes according to their patterns of early embryonic expression ( Fig. 1b) , we delineated l e t t e r S l e t t e r S (i) 1,517 genes whose transcript expression was already detected in oocytes, plateaued up to 4C and abruptly decreased afterward (maternal gene cluster); (ii) 94 genes and 124 genes whose expression started at 2C and peaked at 4C and 8C, respectively, before rapidly decreasing, a pattern consistent with that of early-ZGA genes (2C-4C and 2C-8C gene clusters); and (iii) 1,352 genes expressed only from 4C, peaking at 8C, and then progressively decreasing, as expected for late-ZGA genes (4C-8C gene cluster). Only the two early-ZGA clusters (2C-4C and 2C-8C) were highly enriched in genes upregulated in DUX4overexpressing myoblasts ( Fig. 1c and Supplementary Fig. 1c ).
It is technically challenging to reliably analyze chromatin from the very low number of cells that make up an early embryo, but chromatin immunoprecipitation (ChIP)-seq data obtained in DUX4overexpressing human embryonic stem cells (hESCs) ( Fig. 2a,b and Supplementary Fig. 2 ) and myoblasts 9 (Supplementary Fig. 3 ) showed a marked enrichment of the transcription factor around the annotated transcription start site (TSS) regions of early-ZGA genes (2C-4C and 2C-8C clusters) but not zygotic (maternal) and late-ZGA (4C-8C) genes. Interestingly, several genes were bound not on their annotated TSSs, but on neighboring sequences, and their transcription was found to start near this DUX4-binding site ( Supplementary  Fig. 4 ). DUX4 has been demonstrated to drive expression of many of its target genes from alternative promoters 11 . After examining publicly available single-cell RNA-seq data quantifying the far 5′ ends of transcripts (TFEs) in early human development 13 , we found that the TFEs of 24 out of 31 early-ZGA genes overlapped with DUX4-binding sites (Fig. 2c,d and Supplementary Fig. 3c,d) . DUX4 was also recruited to several groups of transposable elements (TEs), notably endogenous retroviruses such as HERVL, MER11B, and MER11C, whose expression increased at ZGA (Supplementary Fig. 2b,c) . Furthermore, DUX4 overexpression in hESCs led to early-ZGA-gene induction, as previously observed in myoblasts 11 (Fig. 2e) .
Dux and DUX4 have largely conserved amino acid sequences, particularly within the two DNA-binding homeodomains and the l e t t e r S C-terminal region, which has previously been described to be responsible for recruiting p300-CBP 14 (Supplementary Fig. 5b ). The mouse Dux tandem repeat encodes two main transcripts: full-length Dux (or Duxf3) and a variant named Gm4981, which lacks the first homeodomain ( Supplementary Fig. 5a ). Both Dux and Gm4981 are expressed in mouse embryos before ZGA-defining genes and TEs (for example, mouse ERVL or MERVL) at the middle 2C stage, thus indicating that their products are probably functional homologs of DUX4 (ref. 15) ( Fig. 3a) . To consolidate these results, we used mESCs, a small percentage of which, at any given time, display a 2C-like transcriptome in culture, with expression of ZGA genes, including some from the MERVL promoter 16, 17 . After analyzing single-cell RNA-seq data from 2C-like mESCs 18 , we confirmed that Dux transcripts were markedly enriched, as were early-ZGA RNAs such as Zscan4, Zfp352, and Cml2 ( Fig. 3b and Supplementary Fig. 6 ). We used CRISPR-Cas9mediated genome editing to delete the Dux-containing macrosatellite repeat in mESCs expressing a GFP reporter under control of a MERVL promoter, thus resulting in a complete absence of GFP + 2C-like cells and in the loss of a large fraction of 2C-like-cell-specific transcripts (Fig. 3c,d and Supplementary Fig. 7) . Overexpression of Dux but not DUX4 rescued the 2C-like state in the mESC knockout (KO) clones ( Fig. 3e,f and Supplementary Figs. 8 and 9) , albeit not in all cells in which Dux was produced ( Fig. 3g) . Interestingly, both mouse Dux and human DUX4 were able to induce the transcription of ZGA genes in the human 293T cell line ( Supplementary Fig. 10 ).
After depletion of the transcriptional repressor tripartite motifcontaining protein 28 (TRIM28; also known as KAP1) from mESCs, expression of 2C-specific genes increased, as previously observed 17 , as did levels of Dux transcripts ( Fig. 4a and Supplementary  Fig. 11b-d) . Remarkably, this phenotype was completely abrogated in Dux-depleted mESCs (Fig. 4b,c and Supplementary Figs. 9 and 11a-d). Correspondingly, we found that TRIM28 associated with the 5′ end of the Dux gene and that trimethylated histone H3 Lys9 (H3K9me3), a canonical marker of TRIM28-mediated repression, was enriched at the Dux locus and was lost after knockdown (KD) of the heterochromatin inducer ( Fig. 4d and Supplementary Fig. 11e,f) .
Finally, we addressed the role of Dux during mouse early embryonic development. To do so, we injected zygotes with plasmids encoding the Cas9 nuclease and either the two single guide RNAs (sgRNAs) used to generate Dux-KO mESCs or a nontargeting sgRNA control. We then determined the RNA profiles of 2C embryos approximately 7 h after the first cell division or monitored their ex vivo development into blastocysts over 4 d (Fig. 5a) . We found l e t t e r S that Dux-depleted embryos presented a major differentiation defect, in which most failed to reach the morula/blastocyst stage and did not exhibit transcriptional changes typical of ZGA, such as the induction of MERVL, Zscan4, and several other tested early-ZGA genes, and the decrease in the Mpo maternal transcript (Fig. 5b,c and Supplementary Fig. 12 ). l e t t e r S In sum, our data highlight DUX genes as key regulators of early embryonic development. The demonstrated ability of DUX4 to recruit the p300-CBP complex and to induce local chromatin relaxation 14 , as well as the mechanism of action of Zelda, a master inducer of ZGA in Drosophila 19, 20 , suggests that DUX proteins may act as pioneer factors in transcriptional activation, by opening chromatin around the TSSs of early-ZGA genes, thereby facilitating access by other transcription factors. Nonetheless, the genomic recruitment of pioneer factors such as OCT4, NANOG, and KLF4 may be hindered if heterochromatin marks are overly abundant at their target loci 21 . Many mouse ZGA genes are expressed from the long terminal repeats of endogenous retroviruses, which in mESC cells, are typically enriched in repressive marks 17 . At any given time, these marks may be relieved in only a small percentage of mESCs in culture. What drives this fluctuation remains to be determined. Furthermore, what controls expression of DUX genes themselves remains to be defined, although the conserved genomic localization of all placental-mammal DUX orthologs close to telomeric and subcentromeric regions suggests that this genomic context, characterized by high levels of repression, might be of primary relevance 4, 5, 22 . DUX genes indeed appear to be expressed only during events associated with major chromatin relaxation, for instance in early embryos and after loss of repression of the D4Z4 macrosatellite repeat in myoblasts of people with FSHD 23, 24 . Our data indicated that TRIM28 plays a major role in mouse Dux repression, but the mild increase in cells entering the 2C state after TRIM28 depletion (~5% of mESCs) and the demonstrated ability of several other transcriptional modulators (for example, SETDB1, EHMT2, HP1, CHAF1A, CHAF1B, RYBP, and KDM1A) to prevent cycling of mESCs through this state indicate that control of the Dux macrosatellite repeat is most probably multifactorial 16, [25] [26] [27] [28] [29] . Broad derepression of the human and mouse DUX-containing repeats may similarly occur immediately after fertilization in either species. Future investigations of the chromatin states of these loci in early embryos should shed light on the epigenetic changes responsible for this process and on the nature of their molecular mediators.
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Cell culture. mESCs, either WT or KO for Trim28 (ref. 30) , and E14 mESCs containing the MERVL regulatory sequence driving expression of a 3×tur-boGFP-PEST 16 were cultured in feeder-free conditions on 0.1% gelatin-coated tissue culture plates in 2i medium, an N2B27 base medium supplemented with the MEK inhibitor PD0325901 (1 µM), the GSK3β inhibitor CHIR99021 (3 µM), and LIF. E14 mESCs expressed the main markers of pluripotency (RNA-seq). H1 hESCs (WA01, WiCell) were maintained in mTesRI (StemCell Technologies) on hES-qualified Matrigel (BD Biosciences). 293T cells were maintained in DMEM supplemented with 10% FCS. All cells were regularly tested for the absence of mycoplasma contamination.
Plasmids and lentiviral vectors. The MT2/gag sequence was amplified from the pGL3 plasmid 29 , and the human PGK promoter was amplified from pRRLSIN.cPPT.R1R2.PGK-GFP.WPRE 30 and was cloned upstream of luciferase in pGL4.20. Supplementary Table 2 shows the primers used to obtain truncations of the MT2/gag sequence. sgRNAs targeting sequences flanking the 5′ and 3′ ends of the Dux-containing macrosatellite repeat were cloned into px459 (version 2) through a standard protocol 31 . Supplementary Table 2 shows the primers used to clone the sgRNAs. The pLKO.1-puromycin shRNA vector was used for the Trim28 KD 30 . The pLKO.1 vector was further modified to express a blasticidin-S-deaminase drug-resistance cassette in place of the puromycin N-acetyltransferase. The resulting pLKO.1-blasticidin backbone was used to clone shRNAs against the mouse Dux transcript. The sequence of the primers used to clone the Dux shRNA is shown in Supplementary  Table 2 . The Gm4981 cDNA was cloned from the genome of E14 mESCs, and codon-optimized DUX4 and Dux were synthesized (Invitrogen). Gm4981, DUX4, Dux, and LacZ cDNAs were cloned in the pAIB HIV-1-based transfer vector, which also confers blasticidin resistance, by using an In-Fusion HD Cloning Kit (Clontech) 31 . pMD2-G encodes the vesicular stomatitis virus G protein (VSV-G). The minimal HIV-1 packaging plasmid 8.9NdSB, carrying a double mutation in the capsid protein (P90A/A92E), was used to achieve higher transduction of the weakly permissive mESCs 32 .
Production of lentiviral vectors, and transduction and transfection of mammalian cells. Lentiviral vectors were produced by transfection of 293T
cells with polyethylenimine (PEI) (Sigma) 32 . To generate stable KD, mESCs were transduced with empty pLKO.1 vector or vectors for expression of shRNA targeting Trim28 or Dux transcripts 30 . Cells were selected with 1 µg/ml puromycin or 3 µg/ml blasticidin starting 1 d after transduction. hESCs expressing LacZ and DUX4 were generated by transfection of the corresponding AIB plasmids with TransIT-LT1 Transfection Reagent (Mirus Bio), and nucleofection (with an Amaxa P3 Primary Cell 4D-Nucleofector X Kit) was used to engineer mESCs expressing LacZ, DUX4, Dux, and Gm4981.
Creation of Dux-KO mESC lines. E14 mESCs containing the MERVL regulatory sequence driving expression of a 3×turboGFP-PEST were cotransfected with px459 plasmids encoding Cas9, the appropriate sgRNAs and a puromycin-resistance cassette 33 , through nucleofection (Amaxa P3 Primary Cell 4D-Nucleofector X Kit). 24 h later, the cells were selected for 48 h with 1 µg/ml puromycin, single-cell cloned by serial dilution, and expanded, and their DNA was extracted to detect the presence of WT and/or KO alleles. Three WT and three homozygous Dux-KO clones were selected and used in this study.
Luciferase assay. 293T cells or E14 mESCs were cotransfected with the various pGL4.20 derivatives, the Renilla plasmid and the pAIB transfer vector encoding LacZ, Dux, Gm4981, or DUX4, by using Lipofectamine 3000 (Invitrogen). Luciferase activity was quantified 24 h after transfection. Firefly luciferase activity was normalized to the activity of Renilla luciferase. Light emission was measured on a luminescence plate reader.
Immunofluorescence assay. mESC clones expressing an HA-tagged DUX protein were fixed for 20 min with 4% paraformaldehyde, permeabilized for 5 min with 0.1% Triton X-100, and blocked for 30 min with 1% BSA in PBS. Cells were then incubated for 1 h with anti-HA.11 (Covance), anti-NANOG (61628, Active Motif), or anti-SOX2 (39824, Active Motif) antibodies diluted in PBS with 1% BSA. Validation information is available on the manufacturers' websites. After being washed three times, the cells were incubated with anti-mouse (for HA) or anti-rabbit (for NANOG and SOX2) Alexa Fluor 647-conjugated secondary antibodies for 1 h and washed again three times. Every step until this point was carried out with cells in suspension. Pelleted cells were then resuspended in VECTASHIELD Mounting Medium with DAPI (Vector Laboratories) and mounted on the coverslip. The slides were viewed with a Zeiss LSM700 confocal microscope.
Fluorescence-activated cell sorting (FACS). FACS analysis was performed with a BD FACScan system. Trim28-KD mESCs containing the MT2/ gag-GFP reporter were subjected to FACS sorting with an AriaII instrument (BD Biosciences).
Standard PCR, RT-PCR and RNA sequencing. For the genotyping of Dux WT and KO alleles, genomic DNA was extracted with a DNeasy Blood & Tissue Kit (Qiagen), and the specific PCR products were amplified with PCR Master Mix 2× (Thermo Scientific) combined with the appropriate primers (design in Supplementary Fig. 6a ; primer sequences in Supplementary Table 2) .
Total RNA from cell lines was isolated with a High Pure RNA Isolation Kit (Roche). cDNA was prepared with SuperScript II reverse transcriptase (Invitrogen). An Ambion Single Cell-to-CT Kit (Thermo Fisher) was used for RNA extraction, cDNA conversion, and mRNA preamplification of 2C-stage embryos. Primers listed in Supplementary Table 2 were used for SYBR Green qPCR (Applied Biosystems). Library preparation and 150-bp paired-end RNA-seq were performed with standard Illumina procedures for the NextSeq 500 platform (GSE94325).
ChIP and ChIP-seq. ChIP and library preparation were performed as previously described 30 . DUX4-HA ChIP was done with anti-HA.11 (Covance) antibody. Sequencing of TRIM28 and H3K9me3 ChIP was performed with the Illumina HiSeq 2500 platform in 100-bp-read runs. Sequencing of DUX4 ChIP was performed with an Illumina NextSeq 500 in 75-bp paired-end-read runs.
RNA-seq data-set preprocessing. Single-cell RNA-seq of human and mouse early embryo development (GSE36552 and GSE45719 respectively), single-cell RNA-seq of 2C-like cells (E-MTAB-5058), DUX4 overexpression in human myoblasts (GSE45883), and TRIM28-KO (GSE74278) data sets were downloaded from different repositories (NCBI GEO and EBI ArrayExpress) 34, 35 . Reads were mapped to the human genome (hg19) or mouse genome (mm9) with TopHat (v2.0.11) 36 in sensitive mode (the exact parameters were: tophat -g 1 --no-novel-juncs --no-novel-indels -G $gtf --transcriptome-index $ transcriptome --b2-sensitive -o $localdir $index $reads1 $reads2). Gene counts were generated with HTSeq-count. Normalization for sequencing depth and differential gene expression analysis was performed with Voom 37 , as implemented in the limma package of Bioconductor 38 . TEs overlapping exons were removed from the analysis. Counts per TE integrant (genomic loci) were generated with the multiBamCov tool from bedtools software 39 . Normalization for sequencing depth was performed with Voom, with the total number of reads on genes as the size factor. To compute the total number of reads per TE family, counts on all integrants of each family were summed.
Analysis of single-cell expression data from human and mouse embryonic stages.
For every embryonic stage, we identified the genes that had different expression levels compared with those at other stages 10 , by using a moderated F test (comparing the interest group against every other), as implemented in the limma package of Bioconductor. Genes were selected as being expressed in a specific stage if they had a significant P value (<0.05 after adjustment for multiple testing with the Benjamini and Hochberg method) and an average fold change greater than ten, with respect to the other embryonic stages. We additionally removed all genes exhibiting a 1.1-fold-higher expression in any of the embryonic stages compared with the stage analyzed ( Supplementary  Fig. 1a) . Notably, through this approach, a gene may be marked as being expressed in more than one stage. Codes are available upon request.
Correspondence between DUX4 overexpression and single-cell expression
data from human embryonic stages. For every stage, we classified the genes in four patterns of expression by performing hierarchical clustering (with Pearson's correlation as the distance measure and the complete agglomeration method). Figure 1b shows the two most relevant patterns derived from the 4C and 8C stages.
Expression of the genes identified with this method was then compared between DUX4-and GFP-overexpressing human myoblast cells. For a gene to be considered differentially expressed, a P value (after multiple testing correction with the Benjamini and Hochberg method) <0.05 and a fold change greater than two were imposed. A moderated t-test was used as the statistical test, as implemented in the limma package of Bioconductor.
ChIP-seq data processing. The ChIP-seq data set of DUX4 overexpressed in human myoblasts (GSE94325) was downloaded from GEO. Reads were mapped to the human genome assembly hg19 with Bowtie2 by using the sensitive-local mode 40 . SICER was used to call histone-mark peaks 41 . For the peaks that did not represent histone marks, we used MACS (with default parameters) for single-end data and used MACS2 (with the parameters macs2 callpeak -t $chipbam -c $tibam -f BAM -g $org -n $name -B -q 0.01 --format BAMPE) for paired-end data 42 . Both SICER peaks with an FDR >0.05 and MACS peaks with a score <50 were discarded. RSAT was used for motif discovery and to compute motif abundance 43 . To compute the percentage of bound TE integrants in each family, we used the bedtools suite.
Coverage plots. ChIP-seq signals on features of interest were extracted from bigWig files beforehand and normalized for sequencing depth (in reads per hundred million). Each signal was then smoothed with a running window average of 75 bp for DUX4, 250 bp for Trim28, and 500 bp for H3K9me3. Finally, the mean and s.e.m. of the signals were computed and plotted for each set of features of interest. Scripts are available upon request.
Pronuclear injection of mouse embryos. Pronuclear injection was performed according to the standard protocol of the Transgenic Core Facility of EPFL. In brief, five-week-old B6D2F1 mice were used as egg donors. Mice were injected with PMSG (10 IU) and then with HCG (10 IU) 48 h later. After females were mated with B6D2F1 males, zygotes were collected and kept in KSOM pregassed under 5% CO 2 at 37 °C. Embryos were then transferred to M2 medium and microinjected with 10 ng/µg of either a px459 plasmid containing a nontargeting sgRNA or a mix of the two plasmids used to obtain the KO in mESCs, in injection buffer (10 mM Tris-HCl, pH 7.5, 0.1 mM EDTA, pH 8, and 100 mM NaCl). After microinjection, embryos were cultured in KSOM at 37 °C in 5% CO 2 for 4 d. In each of three independent experiments, five embryos per condition were collected approximately 7 h after the first cell division (2C formation) for qPCR analysis, and the remaining embryos were differentiated. At day 4, all the fertilized embryos (16-23 per condition) were classified according to their developmental state. Randomization and blinded outcome assessment were not applied. All animal experiments were approved by the local veterinary office at EPFL and were carried out in accordance with the EU Directive (2010/63/EU) for the care and use of laboratory animals. No statistical method was used to predetermine sample size.
Sample sizes and statistical tests. We used nonparametric statistical tests (two-sided Wilcoxon test), when we had sufficient sample sizes (low-cellnumber qPCR). Otherwise, we used two-sided unpaired t-tests (standard qPCR and FACS). Fisher's exact test was used to test for differences in proportions in contingency tables.
Data availability. RNA-seq and ChIP-seq data generated in this study have been deposited in the NCBI Gene Expression Omnibus (GEO) database under accession number GSE94325.
